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started on cardarone infusion and other supportive measures. But
his liver function went abnormal and so he was put on xyloxcard
infusion. But incessant VT continued and he was shifted to our
hospital by air ambulance. In spite of trying all pharmacological
therapy his VT continued.
So electrophysiological study was planned under CARTOmapping
systemwhich showed ventricular tachyarrhythmiawas automatic
in nature arising from left basal posterior region. Ablation was
performed at 40 W power and 458 temperature at and around the
area of VT origin. Post ablation VT was still inducible but its
frequency had come down signiﬁcantly and the rate was consid-
erably lower. The next day patient was found to have only PVC's
and subsequently he remained in sinus rhythm. His condition
further improved and he was discharged after 7 days. A follow
up after 3monthswithHolter report showed no PVC's or VT and 2D
echo also showed improved ejection fraction to 50%.
Discussion: The clinical spectrum of viral cardiomyopathy can be
classiﬁed as fulminant, acute, or chronic. Viremia is followed by
cardiomyocyte infection. The clinical presentation of viral myo-
carditis varies from nonspeciﬁc electrocardiographic abnormal-
ities and mild viral illness to acute hemodynamic compromise
or sudden cardiac death. The initial evaluation should include
electrocardiography, echocardiography, and often contrast-
enhanced cardiac MRI. Patients with presentations suggestive of
ischemia should usually undergo coronary angiography. Patients
with VT, hemodynamic instability, or high-grade atrioventricular
block should usually undergo endomyocardial biopsy. All patients
should receive standard heart failure care as outlined in the ACC/
AHA/ESC, andHeart Failure Society of America guidelines. Ongoing
trials of antiviral treatment such as the use of interferon beta may
lead to the use of speciﬁc antiviral treatment in the future.
Very few reports are available where successful transcatheter cure
of VT in myocariditis induced dilated cardiomyopathy are avail-
able. The VT and left ventricular dysfunction resolved with suc-
cessful radiofrequency ablation. incessant VT can cause reversible
left ventricular dysfunction. The diagnosis should be suspected in
patients who present with incessant tachycardia and apparent
idiopathic cardiomyopathy. Successful radiofrequency ablation
can resolve the tachycardia and the left ventricular dysfunction.
Conclusion: Suspected viral myocarditis is an important cause of
cardiomyopathy that presents diagnostic and therapeutic chal-
lenges. The initial evaluation should include electrocardiography,
echocardiography, and often contrast-enhanced cardiac MRI. The
indication for ablation in monomorphic ventricular premature
beats is considered exceptional. The recommendation for ablation
in repetitive VT is contemplated in patients with symptoms and
those who fail to respond to or cannot tolerate drug therapy;
tachycardia-induced cardiomyopathy is not mentioned. Consider-
ing that ablation in these tachycardia patients has a success rate of
nearly 80% and a complication rate similar to that of other more
common origins, the indication for this procedure should be
assessed when there is frequent monomorphic ventricular
arrhythmia (premature beats, whether isolated or associated with
repetitive tachycardia) together with apparently idiopathic left-
ventricular dysfunction.
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Background: Electrical storm (ES) is a life-threatening emergency
with an incidence of 10–28% and in-hospital mortality of 60–70%.
We report a single center experience of 8 patients with ES.
Methods: All patients presenting with ES between January 2012
and August 2015 were prospectively enrolled. Clinical proﬁles and
in-hospital outcomes were tabulated. All those discharged were
followed up with review of device data logs.
Results: 8 patients (7 male and 1 female) presented with recurrent
ICD shocks (n = 4) or VT/VF (n = 4) (Table 1). Themean age and LVEF
of the cohort was 57.67  7.67 years and 34.79  4.17% respectively.
6 patients were electively mechanically ventilated and one addi-
tionally required IABP. All received amiodarone, lignocaine and
maximally tolerated dose of beta blockers. Phenytoin and mexiti-
line were given in 1 patient each. 1 patient was found to have
thyrotoxicosis and settled with anti-thyroid drugs. 2 patients
underwent stellate ganglionectomy and 7 patients underwent
VT ablation by 3D mapping. All patients had hemodynamically
unstable VTs of multiple morphologies (3.17  1.6). Strategies for
RFA included substrate modiﬁcation targeting abnormal electro-
grams in scar area (n = 8), isolation of LV aneurysm (n = 1) and
Table 1
Patient
#
Age
(years)
Sex LVEF
(%)
Presentation No of ICD
shocks in
a day
No of DC
shocks
delivered
in ICCU
Rx: RFA/
Stellate/
medical
only
Clinical
substrate
In-
hospital
outcome
Follow
up
(months)
ICD shock
and VT
episodes
1 61 M 30 Recurrent ICD
shocks
7 12 RFA ICM No VT 36 0-0
2 57 M 35 Recurrent VT – 22 RFA NICM No VT 30 0-0
3 65 M 25 Recurrent VT – 25 RFA ICM No VT 29 0-0
4 59 M 30 Recurrent ICD
shocks followed
by incessant VT
26 45 RFA + Stellate ICM No VT 24 0-0
5 54 M 35 Incessant VT/VF – 98 RFA + Stellate Early post
CABG
(4 weeks)
Expired N/A N/A
6 69 M 30 Recurrent VT – 30 RFA ICM No VT 8 0-0
7 46 F 35 Recurrent ICD
shocks
5 0 Medical ICM No VT 7 0-0
8 68 M 25 Recurrent ICD
shocks
4 0 RFA ICM No VT 4 0-0
ICM: ischemic cardiomyopathy; NICU: non-ischemic cardiomyopathy; RFA: radiofrequency ablation.
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mapping VT (n = 1). In 3 patients ICD was implanted after ablation.
7 patients (87.5%) survived to discharge and are on regular follow
up (19.71  12.08 months) and none had any recurrence of VT or
ICD shocks since discharge. 1 patient expired due to pulmonary
complications 2 weeks after ablation.
Conclusion: ES is a challenging clinical problem. VT ablation and
stellate ganglionectomy has improved outcomes.
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Introduction: Improve SCA aims to ﬁnd a group of primary pre-
vention ICD patients with VT/VF treatment rates similar to sec-
ondary prevention patients. The study intends to enroll 4800
patients worldwide, with approximately 1600 coming from India.
We hypothesized rates of ICD implant vary by country.
Methods: At baseline, patients were identiﬁed as either primary or
secondary prevention. Primary prevention patients who met at
least one of four risk criteria (syncope, NSVT, frequent PVCs, or
LVEF < 25%)were identiﬁed as 1.5 patients, thosewho did notmeet
criteria are labeled 1.0 patients. The decision to implant an ICDwas
at the patient's discretion, e.g., to choose whether or not they
wished to receive a device implant.
Results: Through 14 months of study enrollment, 236 out of 994
patients enrolled were from India. The overall average age was
59.0  13.6, with a 74%/26%male/female distribution. Patients had
been enrolled from 12 different countries. Of those enrolled, 825
(158 in India) had complete baseline/implant data, 31% (16% in
India) of whom were secondary prevention patients. Of the pri-
mary prevention patients, 70% (65%) were in the 1.5 category. As
expected, the rate of implant in India varied depending on the
indication, with 92% of secondary prevention patients, 31% of 1.5
patients, and 22% of 1.0 patients choosing implant.
Conclusion: Initial enrollment in the improve SCA study, con-
ducted in emerging countries, has seen a large percentage of
primary prevention patients. Percent of patients declining ICD
therapy varies by indication and country. In India, a greater num-
ber of primary prevention patients have declined implant.
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Introduction: Conduction system disorder is one of the leading
cause of morbidity and mortality in India specially in the eastern
part. Most of the patients present to the emergency department
with bradycardia and asystole and they need to be treated imme-
diately by temporary pacemaker implantation followed by implan-
tation of permanent pacemaker. Although ﬂuoroscopy is needed
for the very purpose, but sometimes due to emergency situation
temporary transvenous pacemaker are implanted without ﬂuoro-
scopy at bedside Guidewire-associated complications can occur
during the process of sheath insertion, eg: kinking, looping, and
knotting. Rarely the wire can be dislodged in the vasculature,
where it can cause vessel damage, major hemorrhage, or embo-
lization to vital structures. We report a case of J-guidewire dis-
lodged accidentally to the right atrium. The guidewire was
successfully withdrawn with the help of a pigtail catheter under
ﬂuoroscopic guidance. The patient remained hemodynamically
stable throughout the procedure. In this way, we averted an open
surgical procedure.
Case report: A 65-year-old diabetic male, known case of CAD, post
CABG presented with 2 episodes of syncope to the emergency
department. His pulse was 20/min and BP was 40 mmHg (systolic).
ECG showed complete heart block. As the cathlab was occupied by
ongoing procedure, so, temporary pacemaker was implanted
through femoral vein immediately after admission at the bedside
and patient became stable. Next day, he was taken to cathlab for
permanent pacemaker implantation. On OT table, when we
checked the position of temporary pacemaker lead, we were sur-
prised to see that the short J-guidewire is present inside the heart;
curved upper end being at the top of right atrium. To avoid open
cardiac surgery, we decided to retrieve the wire under ﬂuoroscopic
guidance. Unfortunately snare was not available, so we tried to
apply some ideas so that it can be removed under ﬂuoroscopy.
First, we removed the temporary pacemaker lead as the patient
was in sinus rhythm at that time. Then, we tried to insert a long
femoral sheath over the lower end of the J-wire with the intent to
insert a PTCA wire and balloon and subsequently to remove the
wire by inﬂating the balloon and pressing the wire against the
inner wall of the sheath. But we failed in the ﬁrst step. Then, we
tried with a handmade snare out of a PTCA wire; again we failed.
Next, we inserted another J-wire and tried to wrap it around the
dislodged wire; but whenever, we tried to pull it, it slipped away.
Finally, we introduced a 5 F pigtail catheter, andwrapped it around
the J-wire. With gentle pull, it came down from right atrium and
the lower end engaged in femoral vein. With a small incision over
femoral vein, we removed the J-wire and we averted an open
surgical procedure.
Discussion: Complete heart block with syncope is one of the
important cardiac emergency and need to treated with immediate
transvenous temporary pacemaker implantation. Although tem-
porary pacemaker lead implantation is a simple procedure, one
should be extremely careful. Preferably, it should be done in the
cathlab. Depending upon personal preferences, it can be done
through femoral, jugular and subclavian vein. After the procedure,
one should always check that the needle, J-wire, dilator is dis-
carded. Snare should always be available at the cathlab. Innovative
ideas can avert many complications. One should have patience
during any complication.
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Introduction: Symptoms caused by sinus node dysfunction (SND),
the most common bradyarrhythmia, can only be mitigated by
permanent cardiac pacing. Yet pacemaker therapy remains under-
utilized in developing regions of the world. The IMPROVE Brady
study is the ﬁrst prospective evaluation aimed to identify factors
related to therapy prescription in underserved regions.
Methods: Patients presenting with symptoms such as fatigue,
shortness of breath, and syncope, a heart rate of ≤50 beats per
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